Immunity for Health Security Symposium

9:00-9:30am:  Welcome and Opening Remarks

Lord Ara Darzi, Imperial College, London; Flagship Pioneering

Robert Langer, David H. Koch Institute, MIT

9:30-9:55am:  Session 1 

Immune Policy and Regulatory Standards

Jeffrey M. Drazen, former Editor New England Journal of Medicine* 

Panel Discussion – Commissioning Standards and Strategies

Lowell M. Zeta, Partner, Hogan Lovells

Hutan Ashrafian, Chief Scientific Officer, Preemptive Medicine and Health Security Initiative, Flagship Pioneering

9:55-11:15am:  Session 2 

Immune Correlates of Protection and Immunity Unknowns for SARS-CoV-2

Miles Davenport, The Kirby Institute, University of New South Wales, Sydney, Australia

Population Testing Technologies and Pathways to Meaningful Result Interpretation

Jay Wohlgemuth, CMO, Quest Diagnostics*

Nigel Clarke, VP R&D and CLO, Quest Diagnostics*

Panel Discussion - Performance, interpretation, and choice considerations for serological test platforms

Laura Gillim, Discipline Director, Infectious Disease Immunology, Labcorp

11:15-11:20am:  Break

11:20-12:00pm:  Session 3

Innovations and Diagnostic Strategies for coming phases of SARS-CoV-2

Panel Discussion & Vote:

Should Antibody testing be utilized in the management and surveillance of COVID?

Lord Ara Darzi, Imperial College, London; Flagship Pioneering*

Michael Osterholm, Center for Infectious Disease Research, University of Minnesota

Eric Topol, Scripps Research Translational Institute

Closing Remarks & Vote Outcome

Lord Ara Darzi, Imperial College, London; Flagship Pioneering

*Moderator